9/30/2024-  Despite its recognition for nearly 40 years, anti-MAG neuropathy continues to have limited therapeutic options. The emergence of bruton tyrosine kinase inhibition as a new therapeutic pathway appears promising. In this interview, Dr. Amro Stino interviews Dr. Chiara Briani on her 2023 paper exploring the prevalence of the MYD 88 mutation among patients with anti-MAG neuropathy. This is discussed within the broader context of disease presentation, current treatment landscape, and future drug development. - 29 minutes

4/15/2024 -Drs. Mohamed Taha and John Morren speak with Andy Galbreath about their recent Muscle & Nerve paper on Artificial Intelligence in NM and EDX Medicine.  The authors discuss concepts of machine learning, deep learning, and artificial neural networks as they relate to NM and EDX medicine. Limitations and regulatory challenges are also discussed.  Muscle & Nerve. 2024;69:260-272. 35 min.

1/5/2024 - Chilvana Patel, Associate Professor and Neurology Residency Program Director at University of Texas Medical Branch Galveston, Texas, interviewing  Dr. Bhai who is an Assistant Professor in the Department of Neurology at UT Southwestern Medical Center and the Director of the Neuromuscular Center in the Institute of Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas and Dr. Vissing who is a professor in Department of Neurology at university of Copenhagen, Denmark and Director of Copenhagen Neuromuscular Center at the National Hospital about their recently published articles in Muscle and Nerve in April 2023 on Diagnosis and management of metabolic myopathies.  34 min.